---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-067928"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2022-03-07T23:59:59+00:00"
generated_at: "2026-06-27T01:09:13.353842+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Jeffrey K. Tong to resign from Nurix board, effective at 2022 annual meeting

## Summary
- Jeffrey K. Tong, Ph.D., will resign as Class II director and from Audit and Compensation Committees.
- Resignation effective as of date of 2022 Annual Meeting of Stockholders.
- Resignation not due to any disagreement with the Company on operations, policies, or practices.

## SEC filing metadata
- accession: 0001193125-22-067928
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2022-03-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000119312522067928/0001193125-22-067928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000119312522067928/d324477d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-067928
- JSON: https://secwatch.observer/filing/0001193125-22-067928.json
- Plain text: https://secwatch.observer/filing/0001193125-22-067928.txt

## Key facts
- Executive change
  Jeffrey K. Tong resigned as Class II Director at Nurix Therapeutics, Inc..
  - Action: resigned
  - Role: Class II Director
  source text: On March 2, 2022, Jeffrey K. Tong, Ph.D., notified the board of directors (the “Board”) of Nurix Therapeutics, Inc. (the “Company”) that he will resign as a Class II member of the Board and as a member of the Board’s Audit Committee and Compensation Committee, effective on the date of the Company’s 2022 Annual Meeting of Stockholders (the “Resignation”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000119312522067928/0001193125-22-067928-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.